Current Psychiatry Reports

, Volume 13, Issue 2, pp 156–165

Genetics of Antipsychotic-induced Side Effects and Agranulocytosis

  • Nabilah I. Chowdhury
  • Gary Remington
  • James L. Kennedy
Article

DOI: 10.1007/s11920-011-0185-3

Cite this article as:
Chowdhury, N.I., Remington, G. & Kennedy, J.L. Curr Psychiatry Rep (2011) 13: 156. doi:10.1007/s11920-011-0185-3

Abstract

Antipsychotic medication has been enormously helpful in the treatment of psychotic symptoms during the past several decades. Unfortunately, several important side effects that can cause significant morbidity and mortality. The two most common are abnormal involuntary movements (tardive dyskinesia) and weight gain progressing through diabetes to metabolic syndrome. A more rare and life-threatening adverse effect is clozapine-induced agranulocytosis (CIA), which has been linked to clozapine use. Clozapine itself has a unique position among antipsychotic medications, representing the treatment of choice in refractory schizophrenia. Unfortunately, the potential risk of agranulocytosis, albeit small, prevents the widespread use of clozapine. Very few genetic determinants have been clearly associated with CIA due to small sample sizes and lack of replication in subsequent studies. The HLA system has been the main hypothesized region of interest in the study of CIA, and several gene variants in this region have been implicated, particularly variants of the HLA-DQB1 locus. A preliminary genome-wide association study has been conducted on a small sample for CIA, and a signal from the HLA region was noted. However, efforts to identify key gene mechanisms that will be useful in predicting antipsychotic side effects in the clinical setting have not been fully successful, and further studies with larger sample sizes are required.

Keywords

AntipsychoticsAgranulocytosisClozapine-induced agranulocytosisTardive dyskinesiaWeight gainGeneticsAssociation studyPharmacogenetics

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Nabilah I. Chowdhury
    • 1
  • Gary Remington
    • 2
  • James L. Kennedy
    • 1
  1. 1.Neurogenetics Section, Neuroscience DepartmentCentre for Addiction and Mental HealthTorontoCanada
  2. 2.Schizophrenia Program, Centre for Addiction and Mental HealthTorontoCanada